82 related articles for article (PubMed ID: 21368902)
1. Innocuous full-length botulinum neurotoxin targets and promotes the expression of lentiviral vectors in central and autonomic neurons.
O'Leary VB; Ovsepian SV; Raghunath A; Huo Q; Lawrence GW; Smith L; Dolly JO
Gene Ther; 2011 Jul; 18(7):656-65. PubMed ID: 21368902
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin.
Edupuganti OP; Ovsepian SV; Wang J; Zurawski TH; Schmidt JJ; Smith L; Lawrence GW; Dolly JO
FEBS J; 2012 Jul; 279(14):2555-67. PubMed ID: 22607388
[TBL] [Abstract][Full Text] [Related]
3. Improved lentiviral transduction of ALS motoneurons in vivo via dual targeting.
O'Leary VB; Ovsepian SV; Bodeker M; Dolly JO
Mol Pharm; 2013 Nov; 10(11):4195-206. PubMed ID: 24066863
[TBL] [Abstract][Full Text] [Related]
4. Internalization and retrograde axonal trafficking of tetanus toxin in motor neurons and trans-synaptic propagation at central synapses exceed those of its C-terminal-binding fragments.
Ovsepian SV; Bodeker M; O'Leary VB; Lawrence GW; Oliver Dolly J
Brain Struct Funct; 2015; 220(3):1825-38. PubMed ID: 25665801
[TBL] [Abstract][Full Text] [Related]
5. Uptake of botulinum neurotoxin into cultured neurons.
Keller JE; Cai F; Neale EA
Biochemistry; 2004 Jan; 43(2):526-32. PubMed ID: 14717608
[TBL] [Abstract][Full Text] [Related]
6. A dileucine in the protease of botulinum toxin A underlies its long-lived neuroparalysis: transfer of longevity to a novel potential therapeutic.
Wang J; Zurawski TH; Meng J; Lawrence G; Olango WM; Finn DP; Wheeler L; Dolly JO
J Biol Chem; 2011 Feb; 286(8):6375-85. PubMed ID: 21138836
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP-25.
Lawrence GW; Ovsepian SV; Wang J; Aoki KR; Dolly JO
Neuropharmacology; 2013 Jul; 70():287-95. PubMed ID: 23485402
[TBL] [Abstract][Full Text] [Related]
8. Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B.
Wang J; Zurawski TH; Bodeker MO; Meng J; Boddul S; Aoki KR; Dolly JO
Biochem J; 2012 May; 444(1):59-67. PubMed ID: 22360156
[TBL] [Abstract][Full Text] [Related]
9. Mastoparan-7 rescues botulinum toxin-A poisoned neurons in a mouse spinal cord cell culture model.
Zhang P; Ray R; Singh BR; Ray P
Toxicon; 2013 Dec; 76():37-43. PubMed ID: 24047963
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vector-mediated reporter gene expression in avulsed spinal ventral root is short-term, but is prolonged using an immune "stealth" transgene.
Hendriks WT; Eggers R; Carlstedt TP; Zaldumbide A; Tannemaat MR; Fallaux FJ; Hoeben RC; Boer GJ; Verhaagen J
Restor Neurol Neurosci; 2007; 25(5-6):585-99. PubMed ID: 18418947
[TBL] [Abstract][Full Text] [Related]
11. [Transduction of recombinant marrow stem cells using lentiviral vector and adenoviral vector: a comparative study].
Ma XS; Jiang JY; Lü FZ; Ma X; Li XK; Huang HY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3340-4. PubMed ID: 17313830
[TBL] [Abstract][Full Text] [Related]
12. Novel chimeras of botulinum and tetanus neurotoxins yield insights into their distinct sites of neuroparalysis.
Wang J; Zurawski TH; Meng J; Lawrence GW; Aoki KR; Wheeler L; Dolly JO
FASEB J; 2012 Dec; 26(12):5035-48. PubMed ID: 22942075
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus transfer of a gene encoding SNAP-25 resistant to botulinum toxin A attenuates neuromuscular paralysis associated with botulism.
Raghunath A; Perez-Branguli F; Smith L; Dolly JO
J Neurosci; 2008 Apr; 28(14):3683-8. PubMed ID: 18385326
[TBL] [Abstract][Full Text] [Related]
14. Botulinum neurotoxin type D enables cytosolic delivery of enzymatically active cargo proteins to neurones via unfolded translocation intermediates.
Bade S; Rummel A; Reisinger C; Karnath T; Ahnert-Hilger G; Bigalke H; Binz T
J Neurochem; 2004 Dec; 91(6):1461-72. PubMed ID: 15584922
[TBL] [Abstract][Full Text] [Related]
15. A protein chip membrane-capture assay for botulinum neurotoxin activity.
Marconi S; Ferracci G; Berthomieu M; Kozaki S; Miquelis R; Boucraut J; Seagar M; Lévêque C
Toxicol Appl Pharmacol; 2008 Dec; 233(3):439-46. PubMed ID: 18845174
[TBL] [Abstract][Full Text] [Related]
16. Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential.
Meng J; Wang J; Lawrence G; Dolly JO
J Cell Sci; 2007 Aug; 120(Pt 16):2864-74. PubMed ID: 17666428
[TBL] [Abstract][Full Text] [Related]
17. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
[TBL] [Abstract][Full Text] [Related]
18. Persistence of botulinum neurotoxin action in cultured spinal cord cells.
Keller JE; Neale EA; Oyler G; Adler M
FEBS Lett; 1999 Jul; 456(1):137-42. PubMed ID: 10452545
[TBL] [Abstract][Full Text] [Related]
19. Primary cell culture for evaluation of botulinum neurotoxin antagonists.
Sheridan RE; Smith TJ; Adler M
Toxicon; 2005 Mar; 45(3):377-82. PubMed ID: 15683877
[TBL] [Abstract][Full Text] [Related]
20. Gene delivery into primary cerebral cortical neurons by lentiviral vector.
Zhang Y; Wang H; Pan H; Bao X; Li M; Jin J; Wu X
Cell Biol Int; 2006 Oct; 30(10):777-83. PubMed ID: 16872845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
